FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Peter Stoll Guilty on Medical Device Felony Count

Former medical device regulatory affairs specialist Peter Stoll pleads guilty on one felony count for distributing medical devices without FDA clearan...

latest-news-card-1
FDA General

CDERs Rosemary Roberts is Retiring

CDER Counterterrorism and Emergency Coordination Staff director Rosemary Roberts announces her retirement this month.

latest-news-card-1
Human Drugs

BIO Backs Rare Disease Endpoint Pilot

The Biotechnology Innovation Organization says FDAs new Rare Disease Endpoint Advancement Pilot Program will provide greater clarity on how to develop...

latest-news-card-1
Medical Devices

FDA Clears BD Alaris Pump Troubles

FDA signs off on a Becton, Dickinson 510(k) that was filed over two years ago to update the firms troubled BD Alaris Infusion System.

latest-news-card-1
Human Drugs

Wuxi Pharmaceutical FDA-483

FDA releases the form FDA-483 with one observation from an inspection at Chinas Wuxi Sta Pharmaceutical contract manufacturing organization.

Medical Devices

Abiomed Recalls All Lots of 6 Heart Pumps

Abiomed recalls all lots of six models of its Impella heart pump due to a potential risk for impeller blade destruction.

Biologics

Vir Flu Vaccine Fails Phase 2 Trial

The Vir Biotechnology VIR-2482 investigational influenza A monoclonal antibody vaccine fails to meet the primary and secondary endpoints in a Phase 2 ...

latest-news-card-1
Human Drugs

Dismiss Norwich Rifaximin Suit: FDA

FDA tells the DC federal court there are five reasons why it should dismiss a Norwich suit seeking to force the agency to approve an amended ANDA for ...

latest-news-card-1
Medical Devices

MediView Surgical Augmented Reality Device Cleared

FDA clears a MediView XR 510(k) for its XR90 augmented reality-based surgical visualization and navigation platform.

latest-news-card-1
Human Drugs

Using ctDNA as an Early Endpoint

Panelists at a Friends of Cancer Research meeting discuss the next steps to help make circulating tumor DNA available as an early endpoint in cancer r...